BRIEF-Newlink Genetics receives $2.8 mln award from DTRA to develop a multivalent filovirus vaccine
April 15, 2016 at 08:55 AM EDT
* Receives $2.8 million award from DTRA to develop a multivalent filovirus vaccine
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.